Financial Advisory Service, Inc. Teva Pharmaceutical Industries LTD Transaction History

Financial Advisory Service, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$7.9 - $10.19 $80,493 - $103,825	-10,189 Closed	0 $0
Q4 2020 Feb 10, 2021	SELL	$8.61 - $11.04 $2,755 - $3,532	-320 Reduced 3.05%	10,189 $98,000
Q2 2020 Jul 21, 2020	SELL	$8.12 - $13.12 $2,874 - $4,644	-354 Reduced 3.26%	10,509 $130,000
Q1 2019 May 13, 2019	SELL	$15.58 - $20.01 $5,141 - $6,603	-330 Reduced 2.95%	10,863 $170,000
Q2 2018 Jul 26, 2018	BUY	$16.77 - $24.71 $3,521 - $5,189	210 Added 1.91%	11,193 $272,000
Q1 2018 May 02, 2018	BUY	$16.68 - $22.07 $183,196 - $242,394	10,983 New	10,983 $188,000

617

563M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Financial Advisory Service, Inc., based on Form 13F filings with the SEC.

Stay updated on Financial Advisory Service, Inc. with notifications on news.